APOE and cholesterol homeostasis in Alzheimer's disease (Q37785392)

23 August 2017

title

APOE and cholesterol homeostasis in Alzheimer's disease (English)

1 reference

23 August 2017

0 references

Valérie Leduc

1 reference

23 August 2017

Stéphanie Jasmin-Bélanger

series ordinal

1 reference

23 August 2017

Judes Poirier

series ordinal

1 reference

23 August 2017

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=20817608

7 July 2024

publication date

1 October 2010

1 reference

full work available at URL

23 August 2017

https://api.elsevier.com/content/article/PII:S1471491410001127?httpAccept=text/xml

1 reference

Crossref

https://api.crossref.org/works/10.1016/J.MOLMED.2010.07.008

https://api.elsevier.com/content/article/PII:S1471491410001127?httpAccept=text/plain

7 July 2024

1 reference

Crossref

https://api.crossref.org/works/10.1016/J.MOLMED.2010.07.008

Trends in Molecular Medicine

7 July 2024

published in

1 reference

23 August 2017

1 reference

23 August 2017

1 reference

23 August 2017

page(s)

469-477

1 reference

Deposition of iron and beta-amyloid plaques is associated with cortical cellular damage in rabbits fed with long-term cholesterol-enriched diets

23 August 2017

cites work

1 reference

3 January 2024

https://opencitations.net/index/api/v1/citations/10.1111/J.1471-4159.2006.04079.X

Alzheimer's disease and the aging brain

1 reference

https://api.crossref.org/works/10.1016/J.MOLMED.2010.07.008

Alzheimer's disease--a sum greater than its parts?

7 July 2024

1 reference

https://api.crossref.org/works/10.1016/J.MOLMED.2010.07.008

Ageing and neuronal vulnerability

7 July 2024

1 reference

https://api.crossref.org/works/10.1016/J.MOLMED.2010.07.008

Vulnerability of select neuronal types to Alzheimer's disease.

7 July 2024

1 reference

https://api.crossref.org/works/10.1016/J.MOLMED.2010.07.008

Amyloid, the presenilins and Alzheimer's disease

7 July 2024

1 reference

https://api.crossref.org/works/10.1016/J.MOLMED.2010.07.008

Apolipoprotein E polymorphism and Alzheimer's disease.

7 July 2024

1 reference

https://api.crossref.org/works/10.1016/J.MOLMED.2010.07.008

Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease

7 July 2024

1 reference

https://api.crossref.org/works/10.1016/J.MOLMED.2010.07.008

Genetic variation in PCDH11X is associated with susceptibility to late-onset Alzheimer's disease

7 July 2024

1 reference

https://api.crossref.org/works/10.1016/J.MOLMED.2010.07.008

GAB2 alleles modify Alzheimer's risk in APOE epsilon4 carriers

7 July 2024

1 reference

https://api.crossref.org/works/10.1016/J.MOLMED.2010.07.008

Candidate single-nucleotide polymorphisms from a genomewide association study of Alzheimer disease

7 July 2024

1 reference

https://api.crossref.org/works/10.1016/J.MOLMED.2010.07.008

Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease

7 July 2024

1 reference

https://api.crossref.org/works/10.1016/J.MOLMED.2010.07.008

Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease

7 July 2024

1 reference

https://api.crossref.org/works/10.1016/J.MOLMED.2010.07.008

Cloning of hippocampal poly(A) RNA sequences that increase after entorhinal cortex lesion in adult rat

7 July 2024

1 reference

https://api.crossref.org/works/10.1016/J.MOLMED.2010.07.008

Dynamics of gene expression for a hippocampal glycoprotein elevated in Alzheimer's disease and in response to experimental lesions in rat.

7 July 2024

1 reference

https://api.crossref.org/works/10.1016/J.MOLMED.2010.07.008

Astrocytic apolipoprotein E mRNA and GFAP mRNA in hippocampus after entorhinal cortex lesioning

7 July 2024

1 reference

https://api.crossref.org/works/10.1016/J.MOLMED.2010.07.008

Alzheimer's disease and vascular dementia in developing countries: prevalence, management, and risk factors

7 July 2024

1 reference

https://api.crossref.org/works/10.1016/J.MOLMED.2010.07.008

Update on hypertension and Alzheimer's disease

7 July 2024

1 reference

https://api.crossref.org/works/10.1016/J.MOLMED.2010.07.008

APOE epsilon4 genotype and longitudinal changes in cerebral blood flow in normal aging

7 July 2024

1 reference

https://api.crossref.org/works/10.1016/J.MOLMED.2010.07.008

Prediction of cognitive decline in normal elderly subjects with 2-[(18)F]fluoro-2-deoxy-D-glucose/positron-emission tomography (FDG/PET).

7 July 2024

1 reference

https://api.crossref.org/works/10.1016/J.MOLMED.2010.07.008

fMRI evidence of compensatory mechanisms in older adults at genetic risk for Alzheimer disease

7 July 2024

1 reference

https://api.crossref.org/works/10.1016/J.MOLMED.2010.07.008

Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families

7 July 2024

1 reference

https://api.crossref.org/works/10.1016/J.MOLMED.2010.07.008

Prevention of dementia in randomised double-blind placebo-controlled Systolic Hypertension in Europe (Syst-Eur) trial

7 July 2024

1 reference

https://api.crossref.org/works/10.1016/J.MOLMED.2010.07.008

Less Alzheimer disease neuropathology in medicated hypertensive than nonhypertensive persons

7 July 2024

1 reference

https://api.crossref.org/works/10.1016/J.MOLMED.2010.07.008

Joint effect of the APOE gene and midlife systolic blood pressure on late-life cognitive impairment: the Honolulu-Asia aging study

7 July 2024

1 reference

https://api.crossref.org/works/10.1016/J.MOLMED.2010.07.008

Does use of antihypertensive drugs affect the incidence or progression of dementia? A systematic review

7 July 2024

1 reference

https://api.crossref.org/works/10.1016/J.MOLMED.2010.07.008

Estrogen replacement therapy for treatment of mild to moderate Alzheimer disease: a randomized controlled trial. Alzheimer's Disease Cooperative Study

7 July 2024

1 reference

https://api.crossref.org/works/10.1016/J.MOLMED.2010.07.008

Apolipoprotein E, cholesterol transport and synthesis in sporadic Alzheimer's disease

7 July 2024

1 reference

https://api.crossref.org/works/10.1016/J.MOLMED.2010.07.008

The absence of ABCA1 decreases soluble ApoE levels but does not diminish amyloid deposition in two murine models of Alzheimer disease.

7 July 2024

1 reference

https://api.crossref.org/works/10.1016/J.MOLMED.2010.07.008

A role for lipoprotein lipase during synaptic remodeling in the adult mouse brain

7 July 2024

1 reference

https://api.crossref.org/works/10.1016/J.MOLMED.2010.07.008

Cholesterol homeostasis in human brain: evidence for an age-dependent flux of 24S-hydroxycholesterol from the brain into the circulation

7 July 2024

1 reference

https://api.crossref.org/works/10.1016/J.MOLMED.2010.07.008

Oxysterols as markers of neurological disease--a review

7 July 2024

1 reference

https://api.crossref.org/works/10.1016/J.MOLMED.2010.07.008

Reduced levels of cholesterol, phospholipids, and fatty acids in cerebrospinal fluid of Alzheimer disease patients are not related to apolipoprotein E4.

7 July 2024

1 reference

https://api.crossref.org/works/10.1016/J.MOLMED.2010.07.008

Membrane lipids, selectively diminished in Alzheimer brains, suggest synapse loss as a primary event in early-onset form (type I) and demyelination in late-onset form (type II).

7 July 2024

1 reference

https://api.crossref.org/works/10.1016/J.MOLMED.2010.07.008

Apolipoprotein E represents a potent gene-based therapeutic target for the treatment of sporadic Alzheimer's disease

7 July 2024

1 reference

https://api.crossref.org/works/10.1016/J.MOLMED.2010.07.008

The neurobiology of apolipoproteins and their receptors in the CNS and Alzheimer's disease

7 July 2024

1 reference

https://api.crossref.org/works/10.1016/J.MOLMED.2010.07.008

Cholesterol synthesis and lipoprotein reuptake during synaptic remodelling in hippocampus in adult rats

7 July 2024

1 reference

https://api.crossref.org/works/10.1016/J.MOLMED.2010.07.008

Differential effects of apolipoproteins E3 and E4 on neuronal growth in vitro

7 July 2024

1 reference

https://api.crossref.org/works/10.1016/J.MOLMED.2010.07.008

Functions of lipoprotein receptors in neurons

7 July 2024

1 reference

https://api.crossref.org/works/10.1016/J.MOLMED.2010.07.008

Uptake of lipoproteins for axonal growth of sympathetic neurons

7 July 2024

1 reference

https://api.crossref.org/works/10.1016/J.MOLMED.2010.07.008

Apolipoprotein E knockout mice display procedural deficits in the Morris water maze: analysis of learning strategies in three versions of the task.

7 July 2024

1 reference

https://api.crossref.org/works/10.1016/J.MOLMED.2010.07.008

Low-density lipoprotein receptor-knockout mice display impaired spatial memory associated with a decreased synaptic density in the hippocampus

7 July 2024

1 reference

https://api.crossref.org/works/10.1016/J.MOLMED.2010.07.008

24S-hydroxycholesterol in cerebrospinal fluid is elevated in early stages of dementia

7 July 2024

1 reference

https://api.crossref.org/works/10.1016/J.MOLMED.2010.07.008

A new role for apolipoprotein E: modulating transport of polyunsaturated phospholipid molecular species in synaptic plasma membranes.

7 July 2024

1 reference

https://api.crossref.org/works/10.1016/J.MOLMED.2010.07.008

Metabolic alterations in postmortem Alzheimer's disease brain are exaggerated by Apo-E4.

7 July 2024

1 reference

https://api.crossref.org/works/10.1016/J.MOLMED.2010.07.008

Evidence for changes in the Alzheimer's disease brain cortical membrane structure mediated by cholesterol

7 July 2024

1 reference

https://api.crossref.org/works/10.1016/J.MOLMED.2010.07.008

CNS synaptogenesis promoted by glia-derived cholesterol

7 July 2024

1 reference

https://api.crossref.org/works/10.1016/J.MOLMED.2010.07.008

Thematic review series: brain Lipids. Cholesterol metabolism in the central nervous system during early development and in the mature animal

7 July 2024

1 reference

https://api.crossref.org/works/10.1016/J.MOLMED.2010.07.008

Polymorphism of apolipoprotein E

7 July 2024

1 reference

https://api.crossref.org/works/10.1016/J.MOLMED.2010.07.008

Plastic neuronal remodeling is impaired in patients with Alzheimer's disease carrying apolipoprotein epsilon 4 allele

7 July 2024

1 reference

https://api.crossref.org/works/10.1016/J.MOLMED.2010.07.008

Induction of Alzheimer-like beta-amyloid immunoreactivity in the brains of rabbits with dietary cholesterol

7 July 2024

1 reference

https://api.crossref.org/works/10.1016/J.MOLMED.2010.07.008

Hypercholesterolemia accelerates the Alzheimer's amyloid pathology in a transgenic mouse model

7 July 2024

1 reference

https://api.crossref.org/works/10.1016/J.MOLMED.2010.07.008

Apolipoprotein E and cholesterol metabolism in the pathogenesis and treatment of Alzheimer's disease

7 July 2024

1 reference

https://api.crossref.org/works/10.1016/J.MOLMED.2010.07.008

The cholesterol-lowering drug probucol increases apolipoprotein E production in the hippocampus of aged rats: implications for Alzheimer's disease

7 July 2024

1 reference

https://api.crossref.org/works/10.1016/J.MOLMED.2010.07.008

Simvastatin strongly reduces levels of Alzheimer's disease beta -amyloid peptides Abeta 42 and Abeta 40 in vitro and in vivo

7 July 2024

1 reference

https://api.crossref.org/works/10.1016/J.MOLMED.2010.07.008

A cholesterol-lowering drug reduces beta-amyloid pathology in a transgenic mouse model of Alzheimer's disease

7 July 2024

1 reference

https://api.crossref.org/works/10.1016/J.MOLMED.2010.07.008

Cholesterol modulates alpha-secretase cleavage of amyloid precursor protein

7 July 2024

1 reference

https://api.crossref.org/works/10.1016/J.MOLMED.2010.07.008

Serum lipoprotein pattern variations in dementia and ischemic stroke.

7 July 2024

1 reference

https://api.crossref.org/works/10.1016/J.MOLMED.2010.07.008

Low-Density Lipoprotein Cholesterol and the Risk of Dementia With Stroke

7 July 2024

1 reference

https://api.crossref.org/works/10.1016/J.MOLMED.2010.07.008

A New Function for the LDL Receptor: Transcytosis of LDL across the Blood–Brain Barrier

7 July 2024

1 reference

https://api.crossref.org/works/10.1016/J.MOLMED.2010.07.008

Body cholesterol metabolism in man. I. The equilibration of serum and tissue cholesterol

7 July 2024

1 reference

https://api.crossref.org/works/10.1016/J.MOLMED.2010.07.008

Apolipoproteins in human cerebrospinal fluid

7 July 2024

1 reference

https://api.crossref.org/works/10.1016/J.MOLMED.2010.07.008

Increased concentrations of cholestanol and apolipoprotein B in the cerebrospinal fluid of patients with cerebrotendinous xanthomatosis. Effect of chenodeoxycholic acid

7 July 2024

1 reference

https://api.crossref.org/works/10.1016/J.MOLMED.2010.07.008

Transbilayer Distribution of Cholesterol Is Modified in Brain Synaptic Plasma Membranes of Knockout Mice Deficient in the Low‐Density Lipoprotein Receptor, Apolipoprotein E, or Both Proteins

7 July 2024

1 reference

https://api.crossref.org/works/10.1016/J.MOLMED.2010.07.008

Amyloid beta-protein interactions with membranes and cholesterol: causes or casualties of Alzheimer's disease

7 July 2024

1 reference

https://api.crossref.org/works/10.1016/J.MOLMED.2010.07.008

Compartmentalization of beta-secretase (Asp2) into low-buoyant density, noncaveolar lipid rafts

7 July 2024

1 reference

https://api.crossref.org/works/10.1016/J.MOLMED.2010.07.008

Low cholesterol stimulates the nonamyloidogenic pathway by its effect on the alpha -secretase ADAM 10.

7 July 2024

1 reference

https://api.crossref.org/works/10.1016/J.MOLMED.2010.07.008

Influence of cholesterol and lovastatin on alpha-form of secreted amyloid precursor protein and expression of alpha7 nicotinic receptor on astrocytes

7 July 2024

1 reference

https://api.crossref.org/works/10.1016/J.MOLMED.2010.07.008

Neuronal membrane cholesterol loss enhances amyloid peptide generation

7 July 2024

1 reference

https://api.crossref.org/works/10.1016/J.MOLMED.2010.07.008

Acyl-coenzyme A: cholesterol acyltransferase modulates the generation of the amyloid beta-peptide

7 July 2024

1 reference

https://api.crossref.org/works/10.1016/J.MOLMED.2010.07.008

Altered cholesterol ester cycle in skin fibroblasts from patients with Alzheimer's disease

7 July 2024

1 reference

https://api.crossref.org/works/10.1016/J.MOLMED.2010.07.008

Apolipoprotein E and beta-amyloid levels in the hippocampus and frontal cortex of Alzheimer's disease subjects are disease-related and apolipoprotein E genotype dependent

7 July 2024

1 reference

https://api.crossref.org/works/10.1016/J.MOLMED.2010.07.008

Impact of apolipoprotein E (ApoE) polymorphism on brain ApoE levels

7 July 2024

1 reference

https://api.crossref.org/works/10.1016/J.MOLMED.2010.07.008

Human APOE isoform-dependent effects on brain beta-amyloid levels in PDAPP transgenic mice.

7 July 2024

1 reference

https://api.crossref.org/works/10.1016/J.MOLMED.2010.07.008

Apolipoprotein E in sporadic Alzheimer's disease: allelic variation and receptor interactions

7 July 2024

1 reference

https://api.crossref.org/works/10.1016/J.MOLMED.2010.07.008

Expression of human apolipoprotein E reduces amyloid-beta deposition in a mouse model of Alzheimer's disease

7 July 2024

1 reference

https://api.crossref.org/works/10.1016/J.MOLMED.2010.07.008

Apolipoprotein E isoform-specific reduction of extracellular amyloid in neuronal cultures

7 July 2024

1 reference

https://api.crossref.org/works/10.1016/J.MOLMED.2010.07.008

Apolipoprotein E promotes the binding and uptake of beta-amyloid into Chinese hamster ovary cells in an isoform-specific manner

7 July 2024

1 reference

https://api.crossref.org/works/10.1016/J.MOLMED.2010.07.008

apoE isoform-specific disruption of amyloid beta peptide clearance from mouse brain

7 July 2024

1 reference

https://api.crossref.org/works/10.1016/J.MOLMED.2010.07.008

Apolipoprotein E is a kinetic but not a thermodynamic inhibitor of amyloid formation: implications for the pathogenesis and treatment of Alzheimer disease

7 July 2024

1 reference

https://api.crossref.org/works/10.1016/J.MOLMED.2010.07.008

Apolipoprotein E isoform-dependent amyloid deposition and neuritic degeneration in a mouse model of Alzheimer's disease

7 July 2024

1 reference

https://api.crossref.org/works/10.1016/J.MOLMED.2010.07.008

The genomic organization and polymorphism analysis of the human Niemann-Pick C1 gene

7 July 2024

1 reference

https://api.crossref.org/works/10.1016/J.MOLMED.2010.07.008

Tangle-bearing neurons contain more free cholesterol than adjacent tangle-free neurons.

7 July 2024

1 reference

https://api.crossref.org/works/10.1016/J.MOLMED.2010.07.008

Effect of aged garlic extract on APP processing and tau phosphorylation in Alzheimer's transgenic model Tg2576.

7 July 2024

1 reference

https://api.crossref.org/works/10.1016/J.MOLMED.2010.07.008

Statins and the risk of dementia

7 July 2024

1 reference

https://api.crossref.org/works/10.1016/J.MOLMED.2010.07.008

Simvastatin is associated with a reduced incidence of dementia and Parkinson's disease

7 July 2024

1 reference

https://api.crossref.org/works/10.1016/J.MOLMED.2010.07.008

Statins are associated with a reduced risk of Alzheimer disease regardless of lipophilicity. The Rotterdam Study

7 July 2024

1 reference

https://api.crossref.org/works/10.1016/J.MOLMED.2010.07.008

Statin therapy is associated with reduced neuropathologic changes of Alzheimer disease

7 July 2024

1 reference

https://api.crossref.org/works/10.1016/J.MOLMED.2010.07.008

Regulation of the mevalonate pathway

7 July 2024

1 reference

https://api.crossref.org/works/10.1016/J.MOLMED.2010.07.008

Usefulness of probucol in treating primary hypercholesterolemia

7 July 2024

1 reference

https://api.crossref.org/works/10.1016/J.MOLMED.2010.07.008

A liver X receptor and retinoid X receptor heterodimer mediates apolipoprotein E expression, secretion and cholesterol homeostasis in astrocytes

7 July 2024

1 reference

https://api.crossref.org/works/10.1016/J.MOLMED.2010.07.008

The LXR agonist TO901317 selectively lowers hippocampal Abeta42 and improves memory in the Tg2576 mouse model of Alzheimer's disease

7 July 2024

1 reference

https://api.crossref.org/works/10.1016/J.MOLMED.2010.07.008

Randomized controlled trial of atorvastatin in mild to moderate Alzheimer disease: LEADe

7 July 2024

1 reference

https://api.crossref.org/works/10.1016/J.MOLMED.2010.07.008

Clinical trial efforts in Alzheimer disease: why test statins?

7 July 2024

1 reference

https://api.crossref.org/works/10.1016/J.MOLMED.2010.07.008

Dynamics of gray matter loss in Alzheimer's disease.

7 July 2024

series ordinal

100

1 reference

Crossref

https://api.crossref.org/works/10.1016/J.MOLMED.2010.07.008

7 July 2024

Identifiers

1 reference

23 August 2017

1 reference